Bob Hopkins
Stock Analyst at B of A Securities
(1.00)
# 3,681
Out of 4,876 analysts
55
Total ratings
56.1%
Success rate
-22.01%
Average return
Main Sectors:
Stocks Rated by Bob Hopkins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | $220 → $255 | $132.41 | +92.58% | 5 | Nov 20, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $90 → $100 | $106.53 | -6.13% | 5 | Oct 22, 2024 | |
| SGHT Sight Sciences | Downgrades: Underperform | $10 → $4.5 | $4.30 | +4.65% | 4 | Sep 13, 2023 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $48 | $56.91 | -15.66% | 1 | Oct 11, 2021 | |
| ABT Abbott Laboratories | Maintains: Buy | $133 | $134.38 | -1.03% | 2 | Aug 31, 2021 | |
| LUNG Pulmonx | Upgrades: Buy | $72 | $2.60 | +2,669.23% | 2 | Mar 10, 2021 | |
| ISRG Intuitive Surgical | Downgrades: Neutral | $242 → $253 | $533.71 | -52.53% | 7 | Sep 8, 2020 | |
| PEN Penumbra | Downgrades: Neutral | n/a | $256.43 | - | 2 | Sep 8, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $85 → $95 | $18.94 | +401.58% | 5 | May 22, 2020 | |
| JNJ Johnson & Johnson | Upgrades: Buy | n/a | $152.41 | - | 2 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $37 → $30 | $93.50 | -67.91% | 2 | Oct 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $105 | $86.02 | +22.06% | 7 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $83 | $30.39 | +173.12% | 6 | May 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $260 | $170.86 | +52.17% | 4 | Jan 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $58.60 | - | 1 | Nov 10, 2017 |
Inspire Medical Systems
Nov 20, 2024
Upgrades: Buy
Price Target: $220 → $255
Current: $132.41
Upside: +92.58%
Boston Scientific
Oct 22, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $106.53
Upside: -6.13%
Sight Sciences
Sep 13, 2023
Downgrades: Underperform
Price Target: $10 → $4.5
Current: $4.30
Upside: +4.65%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $48
Current: $56.91
Upside: -15.66%
Abbott Laboratories
Aug 31, 2021
Maintains: Buy
Price Target: $133
Current: $134.38
Upside: -1.03%
Pulmonx
Mar 10, 2021
Upgrades: Buy
Price Target: $72
Current: $2.60
Upside: +2,669.23%
Intuitive Surgical
Sep 8, 2020
Downgrades: Neutral
Price Target: $242 → $253
Current: $533.71
Upside: -52.53%
Penumbra
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $256.43
Upside: -
Tandem Diabetes Care
May 22, 2020
Maintains: Neutral
Price Target: $85 → $95
Current: $18.94
Upside: +401.58%
Johnson & Johnson
Apr 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $152.41
Upside: -
Oct 31, 2019
Maintains: Underperform
Price Target: $37 → $30
Current: $93.50
Upside: -67.91%
Aug 22, 2018
Maintains: Buy
Price Target: $98 → $105
Current: $86.02
Upside: +22.06%
May 22, 2018
Maintains: Buy
Price Target: $73 → $83
Current: $30.39
Upside: +173.12%
Jan 19, 2018
Reinstates: Buy
Price Target: $260
Current: $170.86
Upside: +52.17%
Nov 10, 2017
Upgrades: Neutral
Price Target: n/a
Current: $58.60
Upside: -